HomeITCI • NASDAQ
add
Intra-Cellular Therapies Inc
Previous close
$78.68
Day range
$78.04 - $79.46
Year range
$45.50 - $84.89
Market cap
8.28B USD
Avg Volume
496.81K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Revenue | 161.39M | 45.67% |
Operating expense | 121.57M | 20.35% |
Net income | -16.22M | 62.09% |
Net profit margin | -10.05 | 73.98% |
Earnings per share | -0.16 | 64.44% |
EBITDA | -27.59M | 41.36% |
Effective tax rate | -0.35% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 1.02B | 99.45% |
Total assets | 1.32B | 85.05% |
Total liabilities | 175.89M | 65.14% |
Total equity | 1.14B | — |
Shares outstanding | 105.67M | — |
Price to book | 7.26 | — |
Return on assets | -6.70% | — |
Return on capital | -7.79% | — |
Cash Flow
Net change in cash
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Net income | -16.22M | 62.09% |
Cash from operations | 542.00K | 101.47% |
Cash from investing | 7.77M | -91.80% |
Cash from financing | 545.18M | 6,250.37% |
Net change in cash | 553.49M | 731.92% |
Free cash flow | -878.88K | 95.91% |
About
Founded
2002
Headquarters
Website
Employees
610